• Explore /
  • Poster
  • / Clinical outcomes of a Dutch prospective observational registry of metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223 (Ra-223).

Clinical outcomes of a Dutch prospective observational registry of metastatic castration resistant prostate cancer (mCRPC) patients treated with radium-223 (Ra-223).

Abstract Poster

Authors

null

Rebecca Louhanepessy

Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

Rebecca Louhanepessy , Sushil Badrising , Vincent van der Noort , Jules L. L. M. Coenen , Paul Hamberg , Aart Beeker , Nils Wagenaar , Marnix G.E.H. Lam , Filiz Celik , Olaf Loosveld , Ad Oostdijk , Johanna Maria Zuetenhorst , Erik Vegt , Wilbert Zwart , Andre M. Bergman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT03223597

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 323)

DOI

10.1200/JCO.2019.37.7_suppl.323

Abstract #

323

Poster Bd #

E9

Abstract Disclosures

Similar Posters

First Author: Daniel J. George

First Author: Celestia S. Higano

First Author: Kim van der Zande

First Author: Oliver A. Sartor